The metabolic effects of drugs used for the treatment of polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. It is characterized by menstrual disorders, hyperandrogenism (clinical and/or biochemical) and ultrasonographic features. It is well known that PCOS has unfavourable effects on carbohydrate metabo...
Saved in:
| Published in: | Journal of the Turkish German Gynecological Association Vol. 14; no. 3; pp. 168 - 173 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
AVES
2013
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. It is characterized by menstrual disorders, hyperandrogenism (clinical and/or biochemical) and ultrasonographic features. It is well known that PCOS has unfavourable effects on carbohydrate metabolism, the parameters of cardiovascular disease and lipid profile. Mode of treatment is mainly guided by the main complaint of the patient. A lot of medicines have been used for many years to treat these women. For that reason the recognition the effects of these drugs on the metabolic risk profile is important. The aim of this review was to evaluate the effects of these drugs on metabolic parameters in women with PCOS. |
|---|---|
| AbstractList | Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. It is characterized by menstrual disorders, hyperandrogenism (clinical and/or biochemical) and ultrasonographic features. It is well known that PCOS has unfavourable effects on carbohydrate metabolism, the parameters of cardiovascular disease and lipid profile. Mode of treatment is mainly guided by the main complaint of the patient. A lot of medicines have been used for many years to treat these women. For that reason the recognition the effects of these drugs on the metabolic risk profile is important. The aim of this review was to evaluate the effects of these drugs on metabolic parameters in women with PCOS. |
| Author | Delibasi, Tuncay Karakose, Melia Cakal, Erman Ertan, Kubilay |
| AuthorAffiliation | 2 Department of Obstetrics and Gynecology, Hospital of Leverkusen, Teaching Hospital of University of Cologne, Leverkusen, Germany 1 Department of Endocrinology and Metabolism, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey |
| AuthorAffiliation_xml | – name: 1 Department of Endocrinology and Metabolism, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey – name: 2 Department of Obstetrics and Gynecology, Hospital of Leverkusen, Teaching Hospital of University of Cologne, Leverkusen, Germany |
| Author_xml | – sequence: 1 givenname: Melia surname: Karakose fullname: Karakose, Melia – sequence: 2 givenname: Erman surname: Cakal fullname: Cakal, Erman – sequence: 3 givenname: Kubilay surname: Ertan fullname: Ertan, Kubilay – sequence: 4 givenname: Tuncay surname: Delibasi fullname: Delibasi, Tuncay |
| BookMark | eNpVkF1LwzAYhYNM3Jy797J_oDNp0ia5EWT4BQNB5nXIZ1dpm5Fkg_572ykDr94D5z2Hw3MLZr3vLQD3CK5LVBYP36mu5bqACK9LSiG6AguEIc8hZnB20ZzPwSrGRkFCKCk5xzdgXoyigJwtwOdub7POJql82-jMOmd1ipl3mQnHOmbHaE3mfMjS-JeClamzfZr8g28HPcQ0pvxJhiGLQ2-C7-wduHayjXb1d5fg6-V5t3nLtx-v75unba4xr1JeWSOh0ozoiiLjGOOEEWMkZqWC3KlKU0ZLZG2BiXK20FyVRHFKHUZVpSq8BI-_vYej6qzR464gW3EITTfOEV424r_TN3tR-5PAvGAETQXwt0AHH2Ow7pJFUEyIxRmxmBCLM2L8A0mJcv8 |
| CitedBy_id | crossref_primary_10_5005_jp_journals_10085_9117 crossref_primary_10_1155_2015_278591 |
| ContentType | Journal Article |
| Copyright | Copyright 2013 by the Turkish-German Gynecological Education and Research Foundation 2013 |
| Copyright_xml | – notice: Copyright 2013 by the Turkish-German Gynecological Education and Research Foundation 2013 |
| DBID | AAYXX CITATION 5PM |
| DOI | 10.5152/jtgga.2013.57701 |
| DatabaseName | CrossRef PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1309-0380 |
| EndPage | 173 |
| ExternalDocumentID | 10_5152_jtgga_2013_57701 |
| GroupedDBID | 29L 2WC 3V. 53G 5GY 6PF 7X7 8FI 8FJ 8R4 8R5 AAWTL AAYXX ABDBF ABUWG ADBBV AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BVXVI CCPQU CITATION DIK EBD EDSIH EOJEC ESX FYUFA GJB GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR M~E N8Y OBODZ OK1 PIMPY PQQKQ PROAC Q2X RNS RPM SW3 TUS UKHRP ~8M 5PM |
| ID | FETCH-LOGICAL-c396t-6eda0bc84c671df889484dda385b09fb6c78751ee234bfe2c9b54b977f3166b63 |
| IEDL.DBID | RPM |
| ISSN | 1309-0399 |
| IngestDate | Tue Sep 17 20:38:18 EDT 2024 Thu Sep 26 19:26:58 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c396t-6eda0bc84c671df889484dda385b09fb6c78751ee234bfe2c9b54b977f3166b63 |
| OpenAccessLink | https://doi.org/10.5152/jtgga.2013.57701 |
| PMID | 24592098 |
| PageCount | 6 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3928416 crossref_primary_10_5152_jtgga_2013_57701 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-00-00 |
| PublicationDateYYYYMMDD | 2013-01-01 |
| PublicationDate_xml | – year: 2013 text: 2013-00-00 |
| PublicationDecade | 2010 |
| PublicationTitle | Journal of the Turkish German Gynecological Association |
| PublicationYear | 2013 |
| Publisher | AVES |
| Publisher_xml | – name: AVES |
| SSID | ssib044745993 ssj0060579 ssib028667282 ssib009969454 |
| Score | 1.9141307 |
| SecondaryResourceType | review_article |
| Snippet | Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. It is characterized by menstrual disorders,... |
| SourceID | pubmedcentral crossref |
| SourceType | Open Access Repository Aggregation Database |
| StartPage | 168 |
| SubjectTerms | Review |
| Title | The metabolic effects of drugs used for the treatment of polycystic ovary syndrome |
| URI | https://pubmed.ncbi.nlm.nih.gov/PMC3928416 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25TgMxELVICkSDOMUZuaCh2GTX6_VRogACoSDEIdGtfIagZBPlQMrfM95sCKGktlz4eaT3xjN-g9CF4cIqY31EdUIiqoSPVGxMJASlRBkJDBGeBu5e-OO7uL4JNjnZ8i9M2bRvdK9Z9AfNovdR9laOBqa17BNrPXXawOmhWtaqoRpowz8pOgh4SVccSQRjnKwMXCjlNJOrz5Ms_MYss7JQJQC6XtQygeZJ63Pa7QZvoiRtZpzHYaoMgc0klmKNxtbbKX_x0-0O2q6EJb5aHGAXbbhiD212qtL5PnqGgMADN4VL7_cMrvo48NBjO551J3g2cRaDgsWgCPFP-3lYHw37czMPfs54-KXGc7x0OThAb7c3r-27qBqoEJlUsmnEnFWxNoIaxhPrhZBUUGtVKjIdS68Z3BzPEudISrV3xEidUQ0K0acJY5qlh6heDAt3hLBMHAgto8JAK0o8JEZSEwUYGRELb-NjdLnEJx8tfDNyyDcCrHkJax5gzUtYjxFfA_BnQ7C-Xl-BiCgtsKsIOPn3zlO0RcrBFuEx5QzVp-OZO0e1iZ01QFjfPzTKoPoGbvbNSA |
| link.rule.ids | 230,315,729,782,786,887,4030,27934,27935,27936,53803,53805 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9pAEF4VKjW9tE2aqvSVPfSSg8Fer_dxrFIiqgKKUir1Zu2TUIFBYFfi33fWGCg95jyag2fG-mZ2Zr5B6LPhwipjfUR1QiKqhI9UbEwkBKVEGQkIEZ4GBj_4-Jf42g80Odl-F6Ye2jd61i3mi24xe6hnK1cL09vPifXuRjeA6aFb1muhp_C_xul_RTqk8JIeUZIIxjg5UrhQymkmj-uTLOxj1nVZ6BMAYO-6mQD0pPe7nE4DO1GSdjPO43BXhoAyiaU4AbLTgcp_EOr25SO_7RV60aSk-MtOfI6euOICPRs1TffX6B5CCS9cCeEynxncTIDgpcd2XU03uNo4iyH3xZBL4sPgepCvlvOt2QYmaLz8o9ZbvOdHuEQ_b_uTm0HUnGKITCpZGTFnVayNoIbxxHohJBXUWpWKTMfSawY-51niHEmp9o4YqTOqIbf0acKYZukb1C6WhXuLsEwcpGhGhVNYlHgoqaQmCmxrRCy8jTvoem_XfLVj3MihUgnuyGt35MEdee2ODuInhj8oBNLsUwnYuybPbuz77tGaV-hsMBkN8-G38ff36Dmpz2OEJ5kPqF2uK_cRtTa2-lSH5F9Kq-Hb |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT-MwELZ4SGgvPBYQb3zYyx7SJI7jxxEBFYiHECzS3iI_S1GbVn0g9d8zTtOW7pE9Oz5kZqzvG8_4G4R-GS6sMtZHVKckokr4SCXGREJQSpSRgBDhauDmhT_-FVfXQSZnPuqrato3ut0oO91G2X6reiv7XRPP-sTip4dLwPRQLYv71seraB3ObJL_k6gDjZd0gZREMMbJQsaFUk5zuXhCycKbzCo3C7UCAO1pRRPAnsTvo1YrKBSlWSPnPAmzZQhsJokUS2C23FT5BaWaW__xf9tos6am-GL6yQ5aceVPtPFQF9930TOEFO66EYRNp21w3QmCex7bwbg1xOOhsxg4MAZOiecN7GG93-tMzCQoQuPehxpM8EwnYQ-9Nq__XN5E9UiGyGSSjSLmrEq0EdQwnlovhKSCWqsyketEes3A9zxPnSMZ1d4RI3VONXBMn6WMaZbto7WyV7oDhGXqgKoZFUZiUeIhtZKaKLCvEYnwNjlEv2e2LfpT5Y0CMpbgkqJySRFcUlQuOUR8yfjzDUE8e3kFbF6JaNc2Pvr2znO08XTVLO5vH--O0Q9STckINzMnaG00GLtTtDq047MqKj8BhsbkWw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+metabolic+effects+of+drugs+used+for+the+treatment+of+polycystic+ovary+syndrome&rft.jtitle=Journal+of+the+Turkish+German+Gynecological+Association&rft.au=Karak%C3%B6se%2C+Melia&rft.au=%C3%87akal%2C+Erman&rft.au=Ertan%2C+Kubilay&rft.au=Deliba%C5%9F%C4%B1%2C+Tuncay&rft.date=2013&rft.pub=AVES&rft.issn=1309-0399&rft.eissn=1309-0380&rft.volume=14&rft.issue=3&rft.spage=168&rft.epage=173&rft_id=info:doi/10.5152%2Fjtgga.2013.57701&rft_id=info%3Apmid%2F24592098&rft.externalDBID=PMC3928416 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1309-0399&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1309-0399&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1309-0399&client=summon |